YU YONG (VP, Clinical Trial Operations) received a stock award from GENELUX CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/29/2025ACC: 0001641172-25-026001
Officer· VP, Clinical Trial Operations
Since Jan 2023
+236K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
236K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+101.48K
Price / share
—
Trade value
—
% of position
209.0%
8/27/2025
48.56K→150.04K
Total
Net shares
+101.48K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/27/2025 | A · Award | +101.48K | — | — | 209.0% | 48.56K | 150.04K |
| Total | +101.48K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common stock
134.52K shares
Shares
+134.52K
Strike price
3.64
Held after
134.52K
Exercisable
—
8/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common stock134.52K shares | 8/27/2025 | A · Award | +134.52K | 3.64 | — | 134.52K |